SOURCE: Cambodian Ventures Limited

October 25, 2005 16:29 ET

Cambodian Ventures Limited Signs Letter of Intent to Acquire Interest in a Biomedical Company Specializing in Human Avian Influenza Solutions

LOWELL, MA and PHNOM PENH, CAMBODIA and MONTREAL, QU -- (MARKET WIRE) -- October 25, 2005 --Cambodian Ventures Limited (OTC: CMBV), announced today that it has signed a letter of intent to acquire up to 25% of Montreal based Canadian Bio Med Systems Inc.

Canadian Bio Med Systems (CBMS) is a company recently formed to provide solutions to the general public in dealing with the containment of the deadly avian influenza A virus (H5N1), also known as "Bird Flu," among humans. Among the founders of CBMS, is Dr. George Tsoukas , M.D., Endocrinologist, Associate Professor, McGill University Health Centre, Montreal, Quebec. Dr. Tsoukas has extensive experience in medical education and has produced and directed a popular television program explaining medical conditions to the public. Dr. Tsoukas was chief examiner for the Quebec College of Endocrinologists He obtained his medical degree at McGill University and received further training in internal medicine, cardiology, and endocrinology. He is a fellow in the Royal College of Physicians and Surgeons of Canada.

CBMS will focus on providing education, preventive and protective products, as well as anti-influenza medications.

As of October 24, 2005, 121 human cases of avian influenza A (H5N1) have been reported since January 2004: 91 in Vietnam, 19 in Thailand, 4 in Cambodia, and 7 in Indonesia, resulting in 62 deaths. For more information about H5N1 infections in humans and the cumulative number of cases, visit the WHO website (http://www.who.int/csr/disease/avian_influenza/en/). Outbreaks of H5N1 among poultry have also been confirmed in Cambodia, China, Thailand, Vietnam, Russia, and Kazakhstan during 2005 and in Malaysia and Laos during 2004.

Since the majority of the human outbreaks have been in the Southeast Asia region, Cambodian Ventures can provide immediate access to CBMS's products for consumers and corporate clients in the region.

Gary Fineberg, CEO of Cambodian Ventures stated, "We feel that the agreement with CBMS will broaden the company's focus in the region and provide valuable products that can potentially help prevent and control the spread of the deadly virus in the human population."

The company anticipates a definitive agreement will be executed within the next 3-4 weeks.

Canadian Bio Med Systems web site www.canadianbiomed.com is in the process of being re-constructed and will be active by November 1.

The company will release further details on Canadian Bio Med Systems in the coming weeks.

Safe Harbor Statement: The statements, other than the statements of historical facts may be deemed to contain forward-looking statements with respect to events, the occurrence of which involves risk and uncertainties, including, without limitation, demand and competition for the company's products and services, the availability to the company of adequate financing to support its anticipated activities, the ability of the company to generate cash flow from operations and the ability of the company to manage its operations.

Contact Information